Eli Lilly Buys Startup CrossBridge Bio to Bring a More Powerful Strike to TumorsNews DeskApril 15, 20260 Antibody drug conjugates continue to be a robust area for research and dealmaking, and Eli Lilly’s latest move in this…
Two New Takes on Making a Type of Targeted Cancer Therapy Even BetterNews DeskApril 12, 20260 Antibody drug conjugates bring a targeted approach to the treatment of many types of cancer, but there’s still room for…